About NeuraMedica

NeuraMedica Inc.

Creator of DuraFuse Spinal Dural Clip

NeuraMedica is a medical device company located in Oregon City, Oregon, focused on the commercialization of DuraFuse, a novel, bioabsorbable, surgical clip for spinal dura closure.

The company was founded in 2014, based on an idea by Neil Roundy, MD, developed out of Oregon Health and Science University (OHSU). Biomedical engineer Rachel Dreilinger developed early prototypes with grants from the OHSU Oregon Clinical and Translational Research Institute (OCTRI). Together they founded NeuraMedica to commercialize the Dural Clip and Applier system.

NeuraMedica holds multiple patents on its proprietary technology and has several pending patents.

Woman-Owned & Led
NeuraMedica is one of the few woman-owned and led medical device companies.
Native-Owned & Led
NeuraMedica is one of the few Native-owned and led (Diné / Navajo) medical device companies.
Patient & Community Focused
NeuraMedica is dedicated to helping patients and supporting its local community and economy.

Meet Our Executives & Board

Co-Founder & CEO
Rachel Dreilinger
Co-Founder & CMO
Neil Roundy, MD
Business Development Advisor & Investor
Michael Tippie

Meet Our Team

Senior Mechanical Engineer
Richard Klein
Mechanical Engineer
Bryon M. Morse
Regulatory Consultant
Tanya Carone, RAC
Clinical Research Consultant
Tamara Baynham, PhD

NeuraMedica Funding

NeuraMedica is proud to have raised more than $3.5 million in funding and grants since 2014.  

DuraFuse dural clip product logo. DuraFuse is a Trademark of NeuraMedica, Inc.


Company History

  • Dural Clip Idea Conceived
    Neil Roundy, MD is awarded seed-level funding from the Oregon Health & Sciences University (OHSU) Oregon Clinical and Translational Research Institute (OCTRI) for a dural clip concept and brings in Rachel Dreilinger as a consultant to develop early-stage prototypes. They develop nine prototypes, file two patent applications, and are awarded a total of $67,000 in grants from OHSU.
  • NeuraMedica Founded
    Ms. Dreilinger and Dr. Roundy decide to partner, co-found NeuraMedica, and continue development of their dural clip prototypes with the intent of creating a game-changing technology for closure of the dura mater.
  • Technology License
    NeuraMedica negotiates an exclusive license from OHSU for their dural clip technology. Oregon Nanoscience and Microtechnologies Institute (ONAMI) invests $250,000. Together, Ms. Dreilinger and Dr. Roundy continue development of their dural clip and applier.
  • ONAMI Grant
    NeuraMedica is awarded a $45,000 Internship Program Grant from ONAMI, allowing the company to hire a PhD to assist with grant-writing. NeuraMedica applies for a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Grant.
  • NSF Grant
    NeuraMedica is awarded a $225,000 NSF SBIR Phase I Grant, finalizes its dural clip design, and begins testing.
  • NIH Grant
    NeuraMedical is awarded a $1,500,000 National Institutes of Health (NIH) grant, $50,000 SBIR Phase 1 Matching Grant from Business Oregon, and raises a $100,000 friends-and-family round of investment to continue development of its dural clip.
  • Business Oregon Grant
    NeuraMedica is awarded an SBIR Phase II Matching Grant from Business Oregon in the amount of $150,000.
  • Animal Study Completed
    NeuraMedica is awarded a $100,000 SBIR Phase II Matching Grant from Business Oregon, and completes its Pivotal Large Animal Study.
  • FDA 510(k) Application
    NeuraMedica raises a $1,000,000 investment from Michael Tippie of Alignment Ventures, is awarded a $50,000 Enhanced Innovation Grant from Business Oregon, completes its Surgeon Usability Study, registers the DuraFuse Trademark, and submits its FDA 510(k) application in December.
  • FDA Clearance
    NeuraMedica receives FDA clearance for its DuraFuse Dural Clip.